The intraperitoneal injection of MSU leads to NLRP3 inflammasome-dependent peritonitis, which is characterized by IL-1β and IL-18 production and the neutrophil influx into the peritoneal cavity [28]. This evidence concerns the gene NLRP3 and peritonitis.